Skip to content

Akreos® AO IOL MI60LRecalls & reported problems

Bausch & Lomb Incorporated · Akreos AO Micro Incision Lens +19.00D · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770502841), received between Nov 28, 2016 and Nov 28, 2016 — classified as 1 injury.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Dislodged or Dislocated1
  • Material Opacification1

Patient problems

  • Corneal Edema1
  • Insufficient Information1
  • Macular Edema1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 28, 2016Material Opacification; Device Dislodged or Dislocated; Adverse Event Without Identified Device or Use Problem; Material Opacification; Device Dislodged or Dislocated; Adverse Event Without Identified Device or Use Problem

    THE CONSUMER REPORTED CLOUDY VISION POST BILATERAL IMPLANTS. REPORTEDLY, A YAG PROCEDURE WAS PERFORMED, BUT IT DID NOT IMPROVE HER VISION. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT HAS NOT BEEN RECEIVED. THIS REPORT REFERENCES THE PATIENT'S LEFT EYE.

    Patient problems: Corneal Edema; Insufficient Information; Macular Edema; Visual Impairment

    MAUDE report 6130199 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page